These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 4338965)

  • 1. The antigen of Bordetella pertussis that induces bactericidal antibody and its relationship to protection of mice.
    Ackers JP; Dolby JM
    J Gen Microbiol; 1972 Apr; 70(2):371-82. PubMed ID: 4338965
    [No Abstract]   [Full Text] [Related]  

  • 2. Taxonomic distribution of the antigen eliciting bactericidal antibody for Bordetella pertussis.
    Dolby JM; Ackers JP
    J Gen Microbiol; 1975 Apr; 87(2):239-44. PubMed ID: 49392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of Bordetella pertussis on the lymphatic tissue of mice. VI. Further studies regarding the influence of Bordetella pertussis on the immunological memory response].
    Finger H; Emmerling P; Fölmer I; Bartoschek M
    Z Gesamte Exp Med Einschl Exp Chir; 1971; 156(4):295-308. PubMed ID: 4335600
    [No Abstract]   [Full Text] [Related]  

  • 4. SYMPOSIUM ON RELATIONSHIP OF STRUCTURE OF MICROORGANISMS TO THEIR IMMUNOLOGICAL PROPERTIES. I. IMMUNOLOGICAL AND OTHER BIOLOGICAL ACTIVITIES OF BORDETELLA PERTUSSIS ANTIGENS.
    MUNOZ JJ
    Bacteriol Rev; 1963 Dec; 27(4):325-40. PubMed ID: 14097343
    [No Abstract]   [Full Text] [Related]  

  • 5. Time relationships between injection of antigen and adjuvant. II. Immunosuppression induced by Bordetella pertussis vaccine when given before secondary antigenic stimulation.
    Finger H; Bartoschek M; Emmerling P
    Pathol Microbiol (Basel); 1972; 38(2):93-102. PubMed ID: 4337644
    [No Abstract]   [Full Text] [Related]  

  • 6. Recovery of the antibody-forming potential in cyclophosphamide-treated mice, with special reference to the influence of Bordetella pertussis.
    Elekes E; Finger H
    Pathol Microbiol (Basel); 1974; 40(1):1-14. PubMed ID: 4358749
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cell components of Bordetella pertussis and their biological activities].
    Sato Y; Arai H
    Tanpakushitsu Kakusan Koso; 1972; 17(2):139-49. PubMed ID: 4337077
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antigen saving function of immunological adjuvants].
    Emmerling P; Finger H; Offenhammer A
    Z Immunitatsforsch Allerg Klin Immunol; 1970 Apr; 139(3):290-300. PubMed ID: 4321654
    [No Abstract]   [Full Text] [Related]  

  • 9. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
    Sato H; Sato Y
    Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of Bordetella endotoxins in bactericidal systems.
    Pusztai Z; Csizér Z; Joó I
    Ann Immunol Hung; 1973; 17():suppl 59-61. PubMed ID: 4376904
    [No Abstract]   [Full Text] [Related]  

  • 11. Murine model for pertussis vaccine encephalopathy: role of the major histocompatibility complex; antibody to albumin and to Bordetella pertussis and pertussis toxin.
    Steinman L; Weiss A; Adelman N; Lim M; Oehlert J; Zuniga R; Hewlett E; Falkow S
    Dev Biol Stand; 1985; 61():439-46. PubMed ID: 2872126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental relation between histamine-sensitizing factor and the protective antigen of Bordetella pertussis].
    Jiménez Paredes J; Ruiz Puente J; González Pacheco M
    Salud Publica Mex; 1981; 23(6):621-9. PubMed ID: 6278660
    [No Abstract]   [Full Text] [Related]  

  • 13. Reaginic-type of antibody in mice stimulated by extracts of Bordetella pertussis.
    Clausen CR; Munoz J; Bergman RK
    J Immunol; 1969 Oct; 103(4):768-77. PubMed ID: 4310738
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular site of action of various adjuvants in antibody responses to hapten-carrier conjugates.
    Hamaoka T; Katz DH
    J Immunol; 1973 Nov; 111(5):1554-63. PubMed ID: 4126779
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
    Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologically active components and properties of Bordetella pertussis.
    Morse SI
    Adv Appl Microbiol; 1976; 20():9-26. PubMed ID: 11644
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations.
    Gracia A; Polewicz M; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
    Vaccine; 2011 Feb; 29(8):1595-604. PubMed ID: 21215343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role and specificity of bordetella lipopolysaccharide in immune reactions.
    Pusztai Z; Csizér Z; Joó I
    Z Immunitatsforsch Allerg Klin Immunol; 1971; 141(2):129-40. PubMed ID: 4323220
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunobiological properties of Bordetella pertussis].
    Kopacka B
    Pediatr Pol; 1972; 47(3):361-70. PubMed ID: 4336329
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the serology of Bordetella pertusis. 3. Biological investigations of antigen fractions of ultrasonic extract obtained by column chromatography on DEAE-cellulose (author's transl)].
    Mebel S; Mucke W; Lapaeva IA; Zakharova MS
    Zentralbl Bakteriol Orig A; 1974 Feb; 226(2):241-7. PubMed ID: 4133229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.